Dennis S. Charney

Dennis S. Charney

Auto-generated profile, based on publicly available information

Dennis S. Charney

Icahn School of Medicine at Mount Sinai, New York, NY, USA

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2012 in Science
Verified
Journal Article
Closed access
PDF file
SSSteven M. Southwick
Steven M. Southwick
DCDennis S. Charney
Dennis S. Charney
Human responses to stress and trauma vary widely. Some people develop trauma-related psychological disorders, such as posttraumatic stress disorder (PTSD) and depression; others develop mild to moderate psychological symptoms that resolve rapidly; still others report no new psychological symptoms in response to traumatic stress. Individual variability in how animals and humans respond to stress and trauma depends on numerous genetic, developmental, cognitive, psychological, and neurobiological risk and protective factors.

1 January 2013 in Frontiers in Behavioral Neuroscience
Verified
Journal Article
Open access
GWGang Wu
Gang Wu
AFAdriana Feder
Adriana Feder
HCHagit Cohen
Hagit Cohen
JKJoanna J. Kim
Joanna J. Kim
SCSolara Calderon
Solara Calderon
AMAleksander A Mathé
Aleksander A Mathé
Resilience is the ability to adapt successfully in the face of stress and adversity. Stressful life events, trauma, and chronic adversity can have a substantial impact on brain function and structure, and can result in the development of posttraumatic stress disorder (PTSD), depression and other psychiatric disorders. However, most individuals do not develop such illnesses after experiencing stressful life events, and are thus thought to be resilient. Resilience as successful adaptation relies on effective responses to environmental challenges and ultimate resistance to the deleterious effects of stress, therefore a greater understanding of the factors that promote such effects is of great relevance. This review focuses on recent findings regarding genetic, epigenetic, developmental, psychosocial, and neurochemical factors that are considered essential contributors to the development of resilience. Neural circuits and pathways involved in mediating resilience are also discussed. The growing understanding of resilience factors will hopefully lead to the development of new pharmacological and psychological interventions for enhancing resilience and mitigating the untoward consequences.

1 January 2015 in Ecology and Society
Verified
Journal Article
Open access
LSLauren M. Sippel
Lauren M. Sippel
RPRobert H. Pietrzak
Robert H. Pietrzak
CSCharney Dennis S
Charney Dennis S
LMLinda Mayes
Linda Mayes
SSSteven M. Southwick
Steven M. Southwick
Sippel, L. M., R. H. Pietrzak, D. S. Charney, L. C. Mayes, and S. M. Southwick. 2015. How does social support enhance resilience in the trauma-exposed individual? Ecology and Society 20(4):10.http://dx.doi.org/10.5751/ES-07832-200410

6 November 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
AVAkhil Vaid
Akhil Vaid
SSSulaiman Somani
Sulaiman Somani
ARAdam J Russak
Adam J Russak
JFJessica K De Freitas
Jessica K De Freitas
FCFayzan Chaudhry
Fayzan Chaudhry
BGBenjamin S Glicksberg
Benjamin S Glicksberg
Background: COVID-19 has infected millions of people worldwide and is responsible for several hundred thousand fatalities. The COVID-19 pandemic has necessitated thoughtful resource allocation and early identification of high-risk patients. However, effective methods to meet these needs are lacking. Objective: The aims of this study were to analyze the electronic health records (EHRs) of patients who tested positive for COVID-19 and were admitted to hospitals in the Mount Sinai Health System in New York City; to develop machine learning models for making predictions about the hospital course of the patients over clinically meaningful time horizons based on patient characteristics at admission; and to assess the performance of these models at multiple hospitals and time points. Methods: We used Extreme Gradient Boosting (XGBoost) and baseline comparator models to predict in-hospital mortality and critical events at time windows of 3, 5, 7, and 10 days from admission. Our study population included harmonized EHR data from five hospitals in New York City for 4098 COVID-19–positive patients admitted from March 15 to May 22, 2020. The models were first trained on patients from a single hospital (n=1514) before or on May 1, externally validated on patients from four other hospitals (n=2201) before or on May 1, and prospectively validated on all patients after May 1 (n=383). Finally, we established model interpretability to identify and rank variables that drive model predictions. Results: Upon cross-validation, the XGBoost classifier outperformed baseline models, with an area under the receiver operating characteristic curve (AUC-ROC) for mortality of 0.89 at 3 days, 0.85 at 5 and 7 days, and 0.84 at 10 days. XGBoost also performed well for critical event prediction, with an AUC-ROC of 0.80 at 3 days, 0.79 at 5 days, 0.80 at 7 days, and 0.81 at 10 days. In external validation, XGBoost achieved an AUC-ROC of 0.88 at 3 days, 0.86 at 5 days, 0.86 at 7 days, and 0.84 at 10 days for mortality prediction. Similarly, the unimputed XGBoost model achieved an AUC-ROC of 0.78 at 3 days, 0.79 at 5 days, 0.80 at 7 days, and 0.81 at 10 days. Trends in performance on prospective validation sets were similar. At 7 days, acute kidney injury on admission, elevated LDH, tachypnea, and hyperglycemia were the strongest drivers of critical event prediction, while higher age, anion gap, and C-reactive protein were the strongest drivers of mortality prediction. Conclusions: We externally and prospectively trained and validated machine learning models for mortality and critical events for patients with COVID-19 at different time horizons. These models identified at-risk patients and uncovered underlying relationships that predicted outcomes.

22 February 2021 in Journal of Medical Internet Research
Verified
Journal Article
Open access
RHRobert P Hirten
Robert P Hirten
MDMatteo Danieletto
Matteo Danieletto
LTLewis Tomalin
Lewis Tomalin
KCKatie Hyewon Choi
Katie Hyewon Choi
MZMicol Zweig
Micol Zweig
ZFZahi A Fayad
Zahi A Fayad
Background: Changes in autonomic nervous system function, characterized by heart rate variability (HRV), have been associated with infection and observed prior to its clinical identification. Objective: We performed an evaluation of HRV collected by a wearable device to identify and predict COVID-19 and its related symptoms. Methods: Health care workers in the Mount Sinai Health System were prospectively followed in an ongoing observational study using the custom Warrior Watch Study app, which was downloaded to their smartphones. Participants wore an Apple Watch for the duration of the study, measuring HRV throughout the follow-up period. Surveys assessing infection and symptom-related questions were obtained daily. Results: Using a mixed-effect cosinor model, the mean amplitude of the circadian pattern of the standard deviation of the interbeat interval of normal sinus beats (SDNN), an HRV metric, differed between subjects with and without COVID-19 (P=.006). The mean amplitude of this circadian pattern differed between individuals during the 7 days before and the 7 days after a COVID-19 diagnosis compared to this metric during uninfected time periods (P=.01). Significant changes in the mean and amplitude of the circadian pattern of the SDNN was observed between the first day of reporting a COVID-19–related symptom compared to all other symptom-free days (P=.01). Conclusions: Longitudinally collected HRV metrics from a commonly worn commercial wearable device (Apple Watch) can predict the diagnosis of COVID-19 and identify COVID-19–related symptoms. Prior to the diagnosis of COVID-19 by nasal swab polymerase chain reaction testing, significant changes in HRV were observed, demonstrating the predictive ability of this metric to identify COVID-19 infection.

4 October 2021 in Psychiatric Quarterly
Verified
Journal Article
Closed access
PDF file
EDEden David
Eden David
Jonathan DePierroJonathan DePierro
Jonathan DePierro
DMDeborah Marin
Deborah Marin
VSVanshdeep Sharma
Vanshdeep Sharma
DCDennis S. Charney
Dennis S. Charney
CKCraig L. Katz
Craig L. Katz